MS-STAT2 Study
STUDY AND PROTOCOL NUMBER
MS-STAT2 CTU/2014/107
STUDY DETAILS
A phase 3 randomised, double-blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo, in secondary progressive multiple sclerosis, in slowing the progression of disability.
FURTHER INFORMATION
ClinicalTrials.gov Identifier: NCT03387670